CTIS2023-507452-77-00进行中（未招募）1 期
Cardiol 100-004
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
This is clinical study to test, for the first time in people, the safety (anygood or bad effects), how long the drug can stay in the body and if it cancontrol the disease of people diagnosed with advanced cancer that has notresponded to treatment, has returned after it has been treated, or cannotbe treated by surgery, drugs, or any other known treatments.CTIS2023-509969-20-00Celgene Corp.133
进行中（未招募）
1 期
A Phase 1 Study of BMS-986406 as Monotherapy and in Combination in Advanced TumorsAdvanced Malignant TumorsMedDRA version: 21.0Level: LLTClassification code: 10048683Term: Advanced cancer Class: 10029104CTIS2023-508280-69-00Bristol Myers Squibb International Corporation112
招募中
1 期
Debio 0123 in combination with carboplatin and etoposide in adult participants with small cell lung cancer that recurred or progressed after platinum-based therapy.MedDRA version: 21.1Level: PTClassification code: 10041067Term: Small cell lung cancer Class: 100000004864Small cell lung cancerCTIS2024-510980-40-00Debiopharm International SA78
招募中
1 期
Trial to evaluate the administration of IDOR-1134-2831 vaccine in healthy participantsClostridioides difficile (C. difficile)MedDRA version: 20.0Level: PTClassification code: 10054236Term: Clostridium difficile infection Class: 100000004862CTIS2023-506407-26-00Idorsia Pharmaceuticals Ltd.125
进行中（未招募）
1 期
A Phase 1b study of inhaled RCT1100 in Adults with Primary Ciliary Dyskinesia Caused by Pathogenic Mutations in the DNAI1 Gene to Measure Mucociliary ClearanceCTIS2023-510521-14-00Recode Therapeutics Inc.12